{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:19:17Z","timestamp":1791951557221,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170775"],"award-info":[{"award-number":["82170775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jbc.2026.111218","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:44:49Z","timestamp":1769618689000},"page":"111218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["CEP55 promotes prostate cancer progression via TPX2-dependent activation of AURKA\u2013PI3K\u2013AKT signaling and inhibition of ferroptosis"],"prefix":"10.1016","volume":"302","author":[{"given":"Lizhe","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhuo","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4415-2968","authenticated-orcid":false,"given":"Jinrun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5500-2121","authenticated-orcid":false,"given":"Pengcheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3471-6221","authenticated-orcid":false,"given":"Fan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111218_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.jbc.2026.111218_bib2","first-page":"92","article-title":"Current role of magnetic resonance imaging in the screening, diagnosis, and treatment of prostate cancer","volume":"61","author":"Nikles","year":"2022","journal-title":"Acta Clin. Croat."},{"key":"10.1016\/j.jbc.2026.111218_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000519861","article-title":"Metastatic prostate cancer: treatment options","volume":"100","author":"Achard","year":"2022","journal-title":"Oncology"},{"key":"10.1016\/j.jbc.2026.111218_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","article-title":"Genomic and phenotypic heterogeneity in prostate cancer","volume":"18","author":"Haffner","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jbc.2026.111218_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygeno.2005.11.006","article-title":"The novel centrosomal associated protein CEP55 is present in the spindle midzone and the midbody","volume":"87","author":"Martinez-Garay","year":"2006","journal-title":"Genomics"},{"key":"10.1016\/j.jbc.2026.111218_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.tcb.2021.07.006","article-title":"Cep55: abscission boss or assistant?","volume":"31","author":"Little","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jbc.2026.111218_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/onc.2015.128","article-title":"Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis","volume":"35","author":"Jeffery","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111218_bib8","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s11010-022-04607-w","article-title":"CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the Foxo1 signaling","volume":"478","author":"Zhang","year":"2023","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.jbc.2026.111218_bib9","article-title":"CEP55 as a promising biomarker and therapeutic target on gallbladder cancer","volume":"13","author":"Huang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2026.111218_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/vaccines12010063","article-title":"Centrosomal protein 55 (CEP55) drives immune exclusion and resistance to immune checkpoint inhibitors in colorectal cancer","volume":"12","author":"Wangmo","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jbc.2026.111218_bib11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.semcancer.2021.09.007","article-title":"Microbiota and prostate cancer","volume":"86","author":"Rizzo","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jbc.2026.111218_bib12","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11912-024-01614-6","article-title":"Prostate cancer, pathophysiology and recent developments in management: a narrative review","volume":"26","author":"Almeeri","year":"2024","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jbc.2026.111218_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.devcel.2005.09.003","article-title":"Cdk1\/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis","volume":"9","author":"Fabbro","year":"2005","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jbc.2026.111218_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1074\/mcp.M400158-MCP200","article-title":"Proteome analysis of the human mitotic spindle","volume":"4","author":"Sauer","year":"2005","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.jbc.2026.111218_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.devcel.2012.05.008","article-title":"BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesis","volume":"23","author":"Mondal","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jbc.2026.111218_bib16","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/ncb2332","article-title":"Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity","volume":"13","author":"Kuo","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111218_bib17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1074\/mcp.M114.046086","article-title":"Myotubularin-related proteins 3 and 4 interact with polo-like kinase 1 and centrosomal protein of 55 kDa to ensure proper abscission","volume":"14","author":"St-Denis","year":"2015","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.jbc.2026.111218_bib18","article-title":"Upregulation of CEP55 predicts dismal prognosis in patients with liver cancer","volume":"2020","author":"Yang","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jbc.2026.111218_bib19","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.2147\/OTT.S165750","article-title":"High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer","volume":"11","author":"Jiang","year":"2018","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.jbc.2026.111218_bib20","first-page":"9549","article-title":"The function and molecular mechanism of CEP55 in anaplastic thyroid cancer","volume":"24","author":"Li","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jbc.2026.111218_bib21","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1039\/C5MB00101C","article-title":"The PI3K\/AKT\/mTOR interactive pathway","volume":"11","author":"Ersahin","year":"2015","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.jbc.2026.111218_bib22","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2026.111218_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/ijms22010173","article-title":"PI3K\/AKT\/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects","volume":"22","author":"Miricescu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111218_bib24","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/ijms25031848","article-title":"Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer","volume":"25","author":"Morgos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111218_bib25","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.3390\/ijms25063178","article-title":"PI3K\/Akt\/mTOR signaling pathway as a target for colorectal cancer treatment","volume":"25","author":"Leiphrakpam","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111218_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/1759-7714.13328","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC)","volume":"11","author":"Tan","year":"2020","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.jbc.2026.111218_bib27","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.3390\/ijms21124507","article-title":"The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling","volume":"21","author":"Shorning","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111218_bib28","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3390\/cells13161397","article-title":"Contribution of AurkA\/TPX2 overexpression to chromosomal imbalances and cancer","volume":"13","author":"Polverino","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2026.111218_bib29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/1947601912473306","article-title":"Mitotic stress and chromosomal instability in cancer: the case for TPX2","volume":"3","author":"P\u00e9rez de Castro","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jbc.2026.111218_bib30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1083\/jcb.200204155","article-title":"Human TPX2 is required for targeting Aurora-A kinase to the spindle","volume":"158","author":"Kufer","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111218_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1242\/jcs.075457","article-title":"Control of Aurora-A stability through interaction with TPX2","volume":"124","author":"Giubettini","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jbc.2026.111218_bib32","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/annonc\/mdv034","article-title":"The AURKA\/TPX2 axis drives colon tumorigenesis cooperatively with MYC","volume":"26","author":"Takahashi","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbc.2026.111218_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3892\/or.2023.8553","article-title":"Bioinformatics and experimental validation of an AURKA\/TPX2 axis as a potential target in esophageal squamous cell carcinoma","volume":"49","author":"Du","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jbc.2026.111218_bib34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.molonc.2012.12.005","article-title":"Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2","volume":"7","author":"Li","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jbc.2026.111218_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2021.09.036","article-title":"Secretory autophagy-induced bladder tumour-derived extracellular vesicle secretion promotes angiogenesis by activating the TPX2-mediated phosphorylation of the AURKA-PI3K-AKT axis","volume":"523","author":"Li","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.111218_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111218_bib37","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111218_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2026.111218_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist Updat"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826000888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826000888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:23:34Z","timestamp":1776381814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826000888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0021925826000888"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111218","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CEP55 promotes prostate cancer progression via TPX2-dependent activation of AURKA\u2013PI3K\u2013AKT signaling and inhibition of ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111218"}}